Focus: Lumenis is a publicly-traded medical device company specializing in energy-based treatments across ophthalmology, aesthetics, and urology, operating at mid-to-large scale with 1,001-5,000 employees.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Lumenis to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Lumenis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Lumenis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Energy-based Aesthetic Devices Market Size to Hit USD 30.81 Billion By 2035 - Precedence Research
Energy-based Aesthetic Devices Market Size to Hit USD 30.81 Billion By 2035 Precedence Research
Institute of Facial Aesthetic Medicine (IFAM) Redefines Medical Aesthetics Education in India - Big News Network.com
Institute of Facial Aesthetic Medicine (IFAM) Redefines Medical Aesthetics Education in India Big News Network.com
Onychomycosis Treatment Market Size, Share, Growth, Analysis, 2034 - Straits Research
Onychomycosis Treatment Market Size, Share, Growth, Analysis, 2034 Straits Research
Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference - PR Newswire
Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference PR Newswire
New Year. New Hair. FoLix(TM) – The first and only FDA-cleared non-invasive laser for hair loss is HERE! - Medianet News Hub
New Year. New Hair. FoLix(TM) – The first and only FDA-cleared non-invasive laser for hair loss is HERE! Medianet News Hub
Treatment Type Analysis - Market.us
Treatment Type Analysis Market.us
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
The potential benefits of periorbital transcutaneous electrical stimulation for the management of dry eye disease.
Multi-Frequency RF Combined with Intense Pulsed Light Improves Signs and Symptoms of Dry Eye Disease Due to Meibomian Gland Dysfunction.
Showing 5 of 9 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo